130 related articles for article (PubMed ID: 10194127)
41. [Inhibition effects of tumor necrosis factor-alpha gene transduced tumor drainage node of lymphocytes from tongue cancer on SCID mice transplanted tumor established with human tongue carcinoma cell lines].
Meng J; Guo W; Zhang ZY; Ren GX; Zhu HG; He Y; Zhou XJ
Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Feb; 28(1):25-8. PubMed ID: 20337069
[TBL] [Abstract][Full Text] [Related]
42. Selective homing of human leukemic B-cell precursors to specific lymphohematopoietic microenvironments in SCID mice: a role for the beta 1 integrin family surface adhesion molecules VLA-4 and VLA-5.
Messinger Y; Chelstrom L; Gunther R; Uckun FM
Leuk Lymphoma; 1996 Sep; 23(1-2):61-9. PubMed ID: 9021687
[TBL] [Abstract][Full Text] [Related]
43. Modulation of leukemic cell growth by tumor necrosis factor: action and expression in myeloid leukemia.
Steffen M; Budde-Steffen C; Gabrilove JL; Moore MA
Leukemia; 1992 Jul; 6(7):634-41. PubMed ID: 1378161
[TBL] [Abstract][Full Text] [Related]
44. Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid mice.
Kamel-Reid S; Letarte M; Doedens M; Greaves A; Murdoch B; Grunberger T; Lapidot T; Thorner P; Freedman MH; Phillips RA
Blood; 1991 Dec; 78(11):2973-81. PubMed ID: 1835412
[TBL] [Abstract][Full Text] [Related]
45. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
Di Fiore R; Guercio A; Puleio R; Di Marco P; Drago-Ferrante R; D'Anneo A; De Blasio A; Carlisi D; Di Bella S; Pentimalli F; Forte IM; Giordano A; Tesoriere G; Vento R
J Cell Biochem; 2012 Nov; 113(11):3380-92. PubMed ID: 22688921
[TBL] [Abstract][Full Text] [Related]
46. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
[TBL] [Abstract][Full Text] [Related]
47. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
48. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
49. Administration of subtumor regression dosage of TNF-alpha to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule.
Lu Y; Yamauchi N; Koshita Y; Fujiwara H; Sato Y; Fujii S; Takahashi M; Sato T; Kato J; Yamagishi H; Niitsu Y
Gene Ther; 2001 Apr; 8(7):499-507. PubMed ID: 11319616
[TBL] [Abstract][Full Text] [Related]
50. Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies.
Mitchell P; Lee FT; Hall C; Rigopoulos A; Smyth FE; Hekman AM; van Schijndel GM; Powles R; Brechbiel MW; Scott AM
J Nucl Med; 2003 Jul; 44(7):1105-12. PubMed ID: 12843229
[TBL] [Abstract][Full Text] [Related]
51. Tumor necrosis factor inhibitors block apoptosis of human epithelial cells of the salivary glands.
Sisto M; D'Amore M; Caprio S; Mitolo V; Scagliusi P; Lisi S
Ann N Y Acad Sci; 2009 Aug; 1171():407-14. PubMed ID: 19723083
[TBL] [Abstract][Full Text] [Related]
52. Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas.
Dolcetti R; Giardini R; Doglioni C; Cariati R; Pomponi F; D'Orazi C; Rao S; Lazarovits AI; Butcher EC; Boiocchi M
Am J Pathol; 1997 May; 150(5):1595-605. PubMed ID: 9137086
[TBL] [Abstract][Full Text] [Related]
53. [Effects and mechanism on anti-leukemic activity of cytokine-induced killer cells with an endogenous expression of interleukin-21].
Zhao N; Zhao MF; Rajbhandary S; Lu WY; Zhu HB; Ma L; You Q; Xiao X; Deng Q; Li YM
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(4):293-9. PubMed ID: 23578511
[TBL] [Abstract][Full Text] [Related]
54. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
55. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
Katschinski DM; Robins HI; Schad M; Frede S; Fandrey J
Cancer Res; 1999 Jul; 59(14):3404-10. PubMed ID: 10416602
[TBL] [Abstract][Full Text] [Related]
56. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
Lu J; Jin J; Xu WL
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066
[TBL] [Abstract][Full Text] [Related]
57. Spin-lattice relaxation in murine tumors after in vivo treatment with interferon alpha/beta or tumor necrosis factor alpha.
Macrì MA; Casieri C; De Luca F; Maraviglia B; Belardelli F; Proietti E; Carpinelli G; Podo F
Magn Reson Med; 1992 Jan; 23(1):12-20. PubMed ID: 1734173
[TBL] [Abstract][Full Text] [Related]
58. Development of a severe combined immunodeficiency (SCID) mouse model consisting of highly disseminated human B-cell leukemia/lymphoma, cure of the tumors by systemic administration of immunotoxin, and development/application of a clonotype-specific polymerase chain reaction-based assay.
Yoshida M; Rybak RJ; Choi Y; Greenberg SJ; Barcos M; Kawata A; Matsuno F; Tsai H; Seon BK
Cancer Res; 1997 Feb; 57(4):678-85. PubMed ID: 9044845
[TBL] [Abstract][Full Text] [Related]
59. Serial transplantation of adult T cell leukemia cells into severe combined immunodeficient mice.
Imada K; Takaori-Kondo A; Sawada H; Imura A; Kawamata S; Okuma M; Uchiyama T
Jpn J Cancer Res; 1996 Sep; 87(9):887-92. PubMed ID: 8878449
[TBL] [Abstract][Full Text] [Related]
60. In vitro and in vivo anti-leukemic efficacy of cyclic AMP modulating agents against human leukemic B-cell precursors.
Myers DE; Chandan-Langlie M; Chelstrom LM; Uckun FM
Leuk Lymphoma; 1996 Jul; 22(3-4):259-64. PubMed ID: 8819074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
